151 related articles for article (PubMed ID: 34410460)
1. Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva.
Funahara R; Soutome S; Funahara M; Tsuda S; Hasegawa T; Umeda M; Akashi M
Support Care Cancer; 2022 Jan; 30(1):907-914. PubMed ID: 34410460
[TBL] [Abstract][Full Text] [Related]
2. Effect of probiotic bacteria on oral
Doppalapudi R; Vundavalli S; Prabhat MP
J Cancer Res Ther; 2020; 16(3):470-477. PubMed ID: 32719253
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study of suppression of candida infection by miconazole mucoadhesive tablets in oral or oropharyngeal cancer patients undergoing radiotherapy.
Soutome S; Otsuru M; Kawashita Y; Yoshimatsu M; Funahara M; Murata M; Ukai T; Umeda M; Saito T
Sci Rep; 2022 Jun; 12(1):10188. PubMed ID: 35715518
[TBL] [Abstract][Full Text] [Related]
4. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
[TBL] [Abstract][Full Text] [Related]
5. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
Koc M; Aktas E
Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: Is topical steroid therapy a risk factor for oral candidiasis?
Kawashita Y; Funahara M; Yoshimatsu M; Nakao N; Soutome S; Saito T; Umeda M
Medicine (Baltimore); 2018 Nov; 97(44):e13073. PubMed ID: 30383690
[TBL] [Abstract][Full Text] [Related]
8. Assessment of saliva and oral candidiasis levels 12, 24 and 36 months after radiotherapy in patients with head and neck cancer.
Boñar-Álvarez P; Padin-Iruegas E; Chamorro-Petronacci C; Gandara-Vila P; Lorenzo-Pouso AI; Somoza-Martin M; Blanco-Carrión A; García-García A; Perez-Sayans M
J Stomatol Oral Maxillofac Surg; 2021 Dec; 122(6):566-572. PubMed ID: 33031953
[TBL] [Abstract][Full Text] [Related]
9. Oral candidiasis in patients receiving radiation therapy for head and neck cancer.
Deng Z; Kiyuna A; Hasegawa M; Nakasone I; Hosokawa A; Suzuki M
Otolaryngol Head Neck Surg; 2010 Aug; 143(2):242-7. PubMed ID: 20647128
[TBL] [Abstract][Full Text] [Related]
10. An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study.
Chitapanarux I; Wongsrita S; Sripan P; Kongsupapsiri P; Phakoetsuk P; Chachvarat S; Kittidachanan K
BMC Oral Health; 2021 Jul; 21(1):353. PubMed ID: 34271901
[TBL] [Abstract][Full Text] [Related]
11. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
[TBL] [Abstract][Full Text] [Related]
12. [Oral candida species distribution in patients receiving radiotherapy for head and neck cancer].
Zhang YY; Li AQ; Wang NN; Liu LN; Cui JL
Shanghai Kou Qiang Yi Xue; 2014 Oct; 23(5):605-8. PubMed ID: 25543608
[TBL] [Abstract][Full Text] [Related]
13. Relationship between oral mucositis and the oral bacterial count in patients with head and neck cancer undergoing carbon ion radiotherapy: A prospective study.
Musha A; Hirai C; Kitada Y; Tsunoda A; Shimada H; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Adachi A; Yokoo S; Chikamatsu K; Ohno T
Radiother Oncol; 2022 Feb; 167():65-71. PubMed ID: 34902372
[TBL] [Abstract][Full Text] [Related]
14. Oral Candida colonization in xerostomic postradiotherapy head and neck cancer patients.
Tarapan S; Matangkasombut O; Trachootham D; Sattabanasuk V; Talungchit S; Paemuang W; Phonyiam T; Chokchaitam O; Mungkung OO; Lam-Ubol A
Oral Dis; 2019 Oct; 25(7):1798-1808. PubMed ID: 31257663
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis.
Jham BC; Chen H; Carvalho AL; Freire AR
J Oral Sci; 2009 Dec; 51(4):565-72. PubMed ID: 20032609
[TBL] [Abstract][Full Text] [Related]
16. Oral Candida species in head and neck cancer patients treated by radiotherapy.
de Freitas EM; Nobre SA; Pires MB; Faria RV; Batista AU; Bonan PR
Auris Nasus Larynx; 2013 Aug; 40(4):400-4. PubMed ID: 23260345
[TBL] [Abstract][Full Text] [Related]
17. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and prevalence of oropharyngeal candidiasis in Spanish patients with head and neck tumors undergoing radiotherapy treatment alone or in combination with chemotherapy.
Mañas A; Cerezo L; de la Torre A; García M; Alburquerque H; Ludeña B; Ruiz A; Pérez A; Escribano A; Manso A; Glaria LA;
Clin Transl Oncol; 2012 Oct; 14(10):740-6. PubMed ID: 22960994
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
Dahiya MC; Redding SW; Dahiya RS; Eng TY; Kirkpatrick WR; Coco BJ; Sadkowski LC; Fothergill AW; Waite A; Rinaldi MG; Patterson TF; Thomas CR
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):79-83. PubMed ID: 12909218
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
